Global Opthalmic Therapeutic Market 2015-2019

10
Global Opthalmic Therapeutic Market 2015-2019 www.technavio.co m enquiry@technavi o.com

Transcript of Global Opthalmic Therapeutic Market 2015-2019

Global Opthalmic Therapeutic Market 2015-2019

[email protected]

USA – CANADA – UK – CHINA – INDIA

Global Opthalmic Therapeutic Market 2015-2019

The report discusses the following in-depth:

• Market Size and Forecast

• Market Segmentation

• Buying Criteria

• Vendor Landscape

• Business Segmentation

• Geographical Segmentation

For more information on theGlobal Opthalmic Therapeutic

Market 2015-2019,please mail us at

[email protected]

USA – CANADA – UK – CHINA – INDIA

Key Trends

Technavio’s Senior Analyst says, “The increase in the prevalence of eye diseases coupled with the high proportion of elderly people propels the market growth. Currently, there is a high unmet need in the market because of the limited availability of approved drugs for visual conditions. Considering this factor, many pharmaceutical companies are investing extensively in the development of drugs for treating optical indications, which is likely to positively influence the market growth.”

• Ophthalmology is the science of eyes. It is the branch of medicine concerned with the treatment of eye-related diseases and eye defects. Some of the common eye disorders are glaucoma, retinal diseases, conjunctivitis, refractive errors, color blindness, and retinitis. Many of the eye diseases do not show symptoms at early stages.

• Technavio's analysts forecast the global ophthalmic therapeutic market to grow at a CAGR of 6.53% over the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge

and trend isavailable in our report:

Global Opthalmic Therapeutic Market 2015-2019

USA – CANADA – UK – CHINA – INDIA

USA – CANADA – UK – CHINA – INDIA

Vendors

To understand the vendor landscape and

for a full list of vendors view our report:

Global Opthalmic Therapeutic Market 2015-2019

Actavis

Bayer

F. Hoffmann-La Roche

Actavis was established in Ireland on May 16, 2013 for facilitating the business combination between Actavis Inc. and Warner Chilcott. It has its global headquarters in Dublin, Ireland and the administrative headquarters are located in New Jersey, US.

Bayer was founded in 1863 and is headquartered in Leverkusen, Germany. It develops, produces, and markets healthcare and agricultural products and high-tech polymer materials.

Roche, a subsidiary of Roche Holding AG, is a healthcare company that undertakes discovery, development, manufacturing, and marketing of innovative diagnostic and therapeutic products and services.

USA – CANADA – UK – CHINA – INDIA

Market Landscape

• The global ophthalmic therapeutics market will grow moderately during the forecast period as the limited availability of medications for the complete treatment of visual diseases is compelling vendors to invest in the R&D of innovative pipeline molecules.

• In addition, strategic alliances among pharmaceutical companies, along with the increased use of combination therapies, will help present and new drugs to penetrate the market and propel the market growth.

• However, the limited public awareness of optical diseases coupled with the availability of alternative treatment options hinders the market growth.

USA – CANADA – UK – CHINA – INDIA

Key Buying Criteria Guest Bloggers

• Authenticity • Delivery • Price• Service

Support

Parameter Details

Efficacy The drugs should prevent the recurrence of ophthalmic diseases.

Safety Drugs for the treatment of ophthalmic diseases should have minimal side effects.

Availability Drugs for the treatment of ophthalmic diseases should be readily available in the market.

Affordability Drugs for the treatment of ophthalmic diseases should be reasonably priced.

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

What Would You Like to Learn From Technavio?

Global Opthalmic Therapeutic Market 2015-2019

Let us identify your needs.We would love to hear more!

USA – CANADA – UK – CHINA – INDIA

Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.

You have the Option to Customize Reports & Access Analysts on every Report Purchase.

Purchasing this report?

For media enquiries,please drop us a mail at

[email protected]

We’ll include an hour with our analysts to discuss the report findings.

For free.

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall

Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION